During the past decade, Ifi - Studien und Projekte GmbH conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ifi - Studien und Projekte GmbH" #1 sponsor was "University of Minnesota" with 2 trials, followed by "ViiV Healthcare" with 2 trials sponsored, "Alexion" with 1 trials sponsored, "CymaBay Therapeutics, Inc." with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ifi - Studien und Projekte GmbH" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Ifi - Studien und Projekte GmbH" are "Hepatitis B, Chronic" (2 trials), "Chronic Hepatitis B" (1 trials), "HIV Coinfection" (1 trials), "HIV Infection" (1 trials) and "HIV-1" (1 trials). Many other conditions were trialed in "Ifi - Studien und Projekte GmbH" in a lesser frequency.

Most popular intervention types in "Ifi - Studien und Projekte GmbH" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Maraviroc" (2 trials), "ALXN1840" (1 trials), "All licensed antiretroviral medications" (1 trials), "Emtricitabine/tenofovir" (1 trials) and "MBX-8025 10 mg Capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ifi - Studien und Projekte GmbH" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Ifi - Studien und Projekte GmbH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Ifi - Studien und Projekte GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ifi - Studien und Projekte GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".